| Similar Articles |
|---|
 |
The Motley Fool
September 27, 2005
Stephen D. Simpson |
Not Bracing for the Worst Price competition and tighter reimbursement? dj Orthopedics isn't worrying about them. Investors may not rush to sell, but they should perhaps start thinking about a protective stop-loss to lock on some easy profits.   |
The Motley Fool
April 28, 2004
Glen Trematore |
Zimmer Makes a Family Proud Zimmer Holdings looks strong when compared with other orthopedic/medical device makers. |
The Motley Fool
August 3, 2005
Steven Mallas |
JNJ: One to Monitor Johnson & Johnson might not exactly be a bargain, but it should always be on your stock watch list. |
The Motley Fool
March 22, 2005
Stephen D. Simpson |
Can Biomet Elbow the Competition? The No. 4 player in orthopedics looks to close the gap. No matter what valuation metric you want to look at, Biomet shares look expensive on an absolute basis. |
The Motley Fool
October 12, 2004
Rich Duprey |
Profit in the Margins Quarterly margin analysis can give you a signal on when to sell. |
The Motley Fool
January 27, 2006
Stephen D. Simpson |
Lightning Stryker The dust hasn't yet settled on the orthopedic sector, so wise investors should tread lightly with this medical technology company. |
The Motley Fool
December 21, 2005
Stephen D. Simpson |
Biomet Takes a Bum Knee Company excuses aside, a subpar quarter lends credence to the notion that orthopedics companies are still in a tough spot. Investors, take note. |
The Motley Fool
March 20, 2006
Rich Smith |
Foolish Forecast: Biomet Flexes The bone specialist is due to release its fiscal third-quarter 2006 report tomorrow morning. Here's what investors need to know to make sense of it. |
Information Today
May 7, 2007 |
News Corp. Offers to Buy Dow Jones--Developing Story News Corp., the media conglomerate owned by Rupert Murdoch, has offered $5 billion to buy Dow Jones & Co. |
The Motley Fool
August 19, 2010
Brian Orelli |
Buffett Is Buying J&J. Should You? It depends on your time horizon. |
The Motley Fool
July 27, 2006
Stephen D. Simpson |
Smith & Nephew: Better Is Good Enough For British medical device company Smith & Nephew investors, better-than-expected is just fine. |
The Motley Fool
May 20, 2011
Andrea Kalvesmaki |
Johnson & Johnson's Billion-Dollar Move Orthopedics are the name of the game for this company's future earnings. |
IndustryWeek
April 1, 2009
Jerry Wright |
The Big Picture: Leadership Insights from the IW Best Plants -- DJO Aims to Never Stop Getting Better Benchmarking helps DJO improve customer service while maintaining a competitive advantage over its competition. |
The Motley Fool
July 14, 2008
Brian Orelli |
Foolish Forecast: J&J Trudges Along In advance of earnings analysts wonder if Johnson & Johnson is a recovery story waiting to happen, or still stuck in a rut? |
The Motley Fool
June 9, 2005
Richard Gibbons |
Buying on Margins Profit margins are one useful tool for finding great stock values. |
The Motley Fool
October 17, 2006
Brian Lawler |
See Johnson & Johnson Crawl Earnings growth isn't moving right along because the company has become so big. Investors, take note. |
The Motley Fool
June 25, 2010
Brian Orelli |
The Joys of Being Large and Diversified Johnson & Johnson's plant closure is a rounding error. |
The Motley Fool
April 26, 2005
Stephen D. Simpson |
Growth Is Knee-High Zimmer turns in another fine quarter, with strength in knee implants leading the way. |
The Motley Fool
October 5, 2005
Stephen D. Simpson |
Wright Goes Wrong A weak third quarter compounds troubles for this pipeline-challenged orthopedics player. There is no compelling reason to purchase this stock today. |
The Motley Fool
January 25, 2005
Tim Beyers |
Still Fit to Print? Operating margins tell a story of decline at The New York Times. |
The Motley Fool
October 19, 2011
Brian Orelli |
Not the Best Quarter, but... There's little reason to worry about Johnson & Johnson. |
The Motley Fool
August 28, 2008
Brian Orelli |
Stryker Strikes Back The orthopedics maker sues to stop a costly federal investigation. |
The Motley Fool
July 27, 2006
Stephen D. Simpson |
Zimmer Provides Quarterly Information, and More In addition to its quarterly review, the orthopedic company gave some insight into the government probe. Investors, take note. |
The Motley Fool
March 9, 2004
Rich Smith |
Interpore Gets Transplanted Will its acquisition by medical equipment maker Biomet pay off for Interpore's shareholders? |
The Motley Fool
June 30, 2005
Stephen D. Simpson |
Biomet Wants Your Body Steady growth continues at the #4 orthopedics player. But Biomet shares haven't had a great year so far, hovering close to their 52-week low. |
PC World
January 2004
Richard Baguley |
Hard-Drive Music Players Dell DJ and Samsung YP-910GS produce good-quality sound. |
The Motley Fool
October 27, 2005
Stephen D. Simpson |
Will Smith & Nephew Keep Flexing? This smaller, British, orthopedic company has competitive products, but industry trends could hurt it. However, the entire orthopedic sector is getting pretty interesting from a value perspective. |
